TD Asset Management’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Sell |
94,588
-6,800
| -7% | -$295K | ﹤0.01% | 792 |
|
|
2025
Q1 | $3.79M | Sell |
101,388
-25,058
| -20% | -$936K | ﹤0.01% | 825 |
|
|
2024
Q4 | $5.73M | Buy |
126,446
+33,000
| +35% | +$1.49M | 0.01% | 773 |
|
|
2024
Q3 | $5.42M | Sell |
93,446
-1,560
| -2% | -$90.5K | ﹤0.01% | 779 |
|
|
2024
Q2 | $3.74M | Sell |
95,006
-53,200
| -36% | -$2.09M | ﹤0.01% | 832 |
|
|
2024
Q1 | $9.85M | Buy |
148,206
+47,360
| +47% | +$3.15M | 0.01% | 630 |
|
|
2023
Q4 | $2.82M | Buy |
100,846
+69,052
| +217% | +$1.93M | ﹤0.01% | 901 |
|
|
2023
Q3 | $677K | Buy |
+31,794
| New | +$677K | ﹤0.01% | 1218 |
|